No Data
No Data
The Tokyo Stock Exchange's Topix 250 Index rebounded, with main stocks recovering and the market showing strength.
Tokyo Stock Exchange Growth Market Index 838.08 +6.25 / Volume 0.1 billion 85.2 million shares / Trading value 124.2 billion yen. Tokyo Stock Exchange Growth Market 250 Index 656.58 +4.80 / Volume 0.1 billion 18.62 million shares / Trading value 106.4 billion yen. The growth market today saw both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index rebounding. The number of rising stocks was 303, the number of falling stocks was 235, and unchanged stocks were 42. The U.S. stock market on the 4th had mixed performance. The Dow Jones Industrial Average was up 38.04 points (+
Gee Dad and other [stocks with potential seen from volume changes]
Stock Closing Price Change from Previous Day Volume * <3841> Jidat 1900 400 2414800 * <7083> AHC Group 1435 119 455100 * <9241> FLN 2016 400 68900 * <6562> Genie 1397 158 835800
Volume Change Rate Ranking (14:00) - Ranking of Media L, Rakkuoria Pharmaceuticals, etc.
In the volume change rate ranking, you can understand the interests of market participants such as the trend of speculation by comparing the volume for the past 5 days with the volume on the delivery day. Top volume change rate [as of August 30, 14:32] (comparison with the average volume for the past 5 days) Code Stock Name Volume 5-day Average Volume Volume Change Rate Price Change Rate <1486> Listed US Bonds 6695 6904.21 345% -0.0006% <9235
Stocks that moved the day before part 2 include Cellseed, SHIFT, Astroscale, etc.
Stock name <code> 19th closing price & rarr; 7&iHD & lt; 3382 & gt; 2161 +400. Foreign securities were downgraded. Nitto Boseki <3110> 5840 +605 showed a golden cross of the day 25-day moving average. Investment funds flowed into Bio-related stocks due to earnings report passage, etc. Cellseed <7776> 671 +100. Tohoku Steel Industry <1835> 3245 +655 formed a golden cross by exceeding the 25-day line and the 75-day line. NetPro HD <7383> 286 +
Emerging market stock digest: Astroscale, Shinbio Pharmaceutical hit the limit.
<186A> Astro Scale Co., Ltd. rose by 150 points to 934, having announced to have signed a large contract for JAXA's (Japan Aerospace Exploration Agency) Commercial Removal of Debris Demonstration (CRD2) Phase II through subsidiary Astro Scale. The contract amount is JPY 1.2 billion (excluding tax) and the contract period will be until the end of March 29. The income has been priced in for the full year consolidated financial estimates for the year ending in April 2025 (project income), but it will be recognized over the contract period.
Hot stocks digest (morning): Sumitomo Pharmaceuticals, Double A, Pan Pacific HD, etc.
MH Group <9439>: 196 yen (-7 yen) significant decline. They announced their financial results for the year ending June 24th after the end of the previous week's trading. Operating profit was 0.023 billion yen, a 57.5% decrease from the previous year. It seems to have been disappointed that it fell to a deficit, about 64% lower than the previous estimate of 0.065 billion yen. This is due to the PB product sales in the BS salon operating business being below expectations, as well as an increase in cost of sales and personnel expenses. Operating profit for the year ending June 25th is 0.03 billion yen, up 29.6% from the previous year.
No Data
No Data